AXSM - Axsome Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development23,277.63719,750.50220,725.5816,776.987
Selling General and Administrative9,351.5227,206.6916,343.6482,419.289
Non Recurring----
Others----
Total Operating Expenses32,629.15926,957.19327,069.2299,196.276
Operating Income or Loss-32,629.159-26,957.193-27,069.229-9,196.276
Income from Continuing Operations
Total Other Income/Expenses Net1,663.695-1,986.199-132.424-3,014.303
Earnings Before Interest and Taxes-32,629.159-26,957.193-27,069.229-9,196.276
Interest Expense-1,127.305-1,340.199-132.424-736.048
Income Before Tax-30,965.464-28,943.392-27,201.653-12,210.579
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-30,965.464-28,943.392-27,201.653-12,210.579
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-30,965.464-28,943.392-27,201.653-12,210.579
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-30,965.464-28,943.392-27,201.653-12,210.579